UBS - UBS Group AG
NYSE
->
Financial Services
->
Banks—Diversified
Zurich,
Switzerland
Type: Equity
UBS price evolution
UBS
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $16571 | $16440 | $16770 | $17849 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1623941 | $1560976 | $1607120 | $1717569 |
| Current liabilities | ||||
| Accounts payable | $75186 | $67942 | $66071 | $56916 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $148306 | $141217 | $147005 | $98498 |
| Long term debt | $310629 | $312585 | $315785 | $366106 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1536916 | $1477293 | $1521860 | $1630284 |
| Shareholders' equity | ||||
| Retained earnings | $77197 | $76176 | $76436 | $76057 |
| Other shareholder equity | $3778 | $917 | $663 | $2462 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 7 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $203240 | $169801 | ||
| Short term investments | $567548 | $408305 | $374610 | |
| Net receivables | $141237 | $85390 | $96851 | $99445 |
| Inventory | ||||
| Total current assets | $1662777 | $1065152 | $1077519 | $599619 |
| Long term investments | $54468 | $39211 | $39662 | $116075 |
| Property, plant & equipment | $17849 | $12288 | $12888 | $9328 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1717569 | $1104364 | $1117181 | $1125765 |
| Current liabilities | ||||
| Accounts payable | $56916 | $49287 | $542007 | $524605 |
| Deferred revenue | ||||
| Short long term debt | $366106 | $188259 | $212954 | $50024 |
| Total current liabilities | $98498 | $49287 | $1056179 | $909535 |
| Long term debt | $366106 | $188259 | $133521 | $121155 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1630284 | $1047488 | $1056519 | $1066001 |
| Shareholders' equity | ||||
| Retained earnings | $76057 | $50004 | $43851 | $38776 |
| Other shareholder equity | $2462 | -$104 | $5236 | $7646 |
| Total shareholder equity | $86108 | $56877 | $60662 | $59445 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $13327 | |||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $612 | |||
| Interest expense | ||||
| Net income | ||||
| Net income | $1755 | |||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 7 Mar 2023 | 31 Jan 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $43029 | $42950 | $32386 | |
| Cost of revenue | $29 | |||
| Gross Profit | $42921 | $32386 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $5189 | $24106 | ||
| Total operating expenses | $33346 | $24106 | ||
| Operating income | $9604 | $8280 | ||
| Income from continuing operations | ||||
| EBIT | $9604 | |||
| Income tax expense | $873 | $1942 | $1583 | |
| Interest expense | $2948 | |||
| Net income | ||||
| Net income | $29027 | $7630 | $6557 | |
| Income (for common shares) | $7630 | $6557 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $1807 | $2549 | $1315 | $103228 |
| Financing activities | ||||
| Dividends paid | -$2256 | -$2256 | -$1679 | |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$80073 | -$61916 | -$40818 | -$58262 |
| Effect of exchange rate | -$2492 | -$13733 | -$12852 | $13955 |
| Change in cash and equivalents | -$64797 | -$61242 | -$40811 | $144989 |
| (in millions $) | 31 Jan 2024 | 7 Mar 2023 | 7 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $7630 | $7457 | $6557 | |
| Operating activities | ||||
| Depreciation | $2061 | $2118 | $1238 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $14646 | $31426 | -$14847 | |
| Investing activities | ||||
| Capital expenditures | -$1643 | -$1841 | -$1854 | |
| Investments | -$5926 | |||
| Total cash flows from investing | $103228 | -$12447 | -$2119 | -$6785 |
| Financing activities | ||||
| Dividends paid | -$1679 | -$2607 | ||
| Sale and purchase of stock | ||||
| Net borrowings | -$622058 | -$574897 | $16433 | |
| Total cash flows from financing | -$58262 | -$9095 | $10346 | $64237 |
| Effect of exchange rate | $13955 | $11052 | ||
| Change in cash and equivalents | $144989 | -$23372 | $34586 | $53657 |
News
Fundamentals
| Market cap | $121.12B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 3.19B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 18.93 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |